The sessions on 13 June 2014, supported by the CML Advocates Network and Thalassaemia International Foundation, were very popular not only for hematologists, but also nurses, researchers and patient advocates attended the various session
The first of the two EHA Patient Advocacy Sessions organized by the patient community addressed the issue of “Generics in Haematology: The doctors’ and patients’ perspective”. Generics are of increasing relevance in haematology in a growing number of countries and indications where EMA-approved generics or imported, locally approved drugs are being introduced. This session was co-chaired by Jan Geissler, CML Advocates Network, and Dr Androulla Eleftheriou, TIF Executive Director.
Read more information